Work

Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized Trial

Year: 2025

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The American Journal of Gastroenterology

DOI: 10.14309/ajg.0000000000003607

Authors: Ping-I Hsu, Chien-Lin Chen, Chih-An Shih, Kuan-Yang Chen, Wei-Chen Tai, Seng-Kee Chuah, Chia-Long Lee, Feng-Woei Tsay, Jyh-Chin Yang, Wei-Yi Lei, Chao-Hung Kuo, Chang-Bih Shie, Hsi-Chang Lee, Yoshio Yamaoka, David Y. Graham, Deng-Chyang Wu

Institutions: China Medical University, An-Nan Hospital, Tzu Chi University, Buddhist Tzu Chi General Hospital, Meiho University, Taipei City Hospital, Chang Gung University, Kaohsiung Chang Gung Memorial Hospital, Cathay General Hospital, Kaohsiung Veterans General Hospital, National Yang Ming University, National Taiwan University, National Taiwan University Hospital, Kaohsiung Medical University, Kaohsiung Medical University Chung-Ho Memorial Hospital, Baylor College of Medicine, Oita University, Michael E. DeBakey VA Medical Center

Language: English

Topic: Helicobacter pylori-related gastroenterology studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Tainan Municipal An-Nan Hospital

Awards: G2049462271, G3221527295

OpenAlex ID: W4411627329

FWCI: 5.211

Cites: 44

Cited by: 6

Related to: 10